Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
Every day, the cosmetics and pharmaceuticals we rely on release a hidden torrent of toxic chemicals into our wastewater. An alarming 92% of these pollutants, which are notoriously persistent and harmful to aquatic life, come from these sources. Demeter Bio was established to tackle this invisible crisis head-on. Their initial goal to detoxify our water systems has blossomed into a pioneering biotech venture that uses natural processes to engineer the world’s first generation of truly clean, biodegradable ingredients.
Confronting a hidden crisis
The team behind Demeter Bio identified a critical market failure. While consumers increasingly demanded cleaner, non-toxic products, the chemical ingredients industry offered few, if any, high-performing and genuinely safe alternatives. This gap in the market sparked a powerful idea: what if biotechnology and circular economy principles could be combined to create ingredients that were both effective and harmless to the environment?
Their ambition was far greater than creating a single "eco-friendly" product. They envisioned an entire platform capable of upcycling industrial waste streams into valuable, sustainable materials. By leveraging the unique biological capabilities of insects, Demeter Bio set out to create a solution that could simultaneously reduce waste, stop water pollution at its source, and supply the personal care industry with the safe ingredients it urgently needs.
Harnessing biology for a scientific breakthrough
Translating this concept into a commercial product demanded sophisticated scientific innovation. The result is Demeter Bio’s proprietary MelioShield technology, a major leap forward in industrial biotechnology. The technology’s core process utilizes black soldier flies—insects well-known for their efficiency as waste converters—as a sustainable biological factory. These flies consume waste and are then processed to create novel, bio-based compounds that can replace synthetic chemicals.
The platform's first revolutionary product is the world's first fully biodegradable UV filter for sunscreens. It serves as a "drop-in" replacement for common chemical filters known to be toxic to coral reefs and other marine life. By engineering a safe, natural, and effective alternative, Demeter Bio is removing a key obstacle to producing truly reef-safe sun protection. This scalable process means the company is not just a niche player, but a vital industrial partner in solving a global pollution crisis.
Accelerating market disruption with Carbon13
Demeter Bio’s journey shows how cutting-edge biotech can seek to deliver huge environmental benefits and achieve commercial scale. However, taking on the multi-billion-pound chemical ingredients market is a monumental task requiring substantial capital for R&D and production. For deep-tech ventures facing these exact hurdles, a specialised partner like the venture builder Carbon13 is indispensable. Carbon13’s investment strategy is focused on high-impact companies like Demeter Bio that have the potential to detoxify and decarbonise entire industrial supply chains.
Demeter Bio's progress is a prime illustration of the powerful ventures cultivated within the Carbon13 ecosystem. The programme equips founders with the scientific expertise, industry connections, and strategic guidance necessary to build a world-changing concept into an investable, high-growth potential business. The company’s mission to design out toxic pollution from consumer goods aligns perfectly with Carbon13’s fundamental goal of healing environmental damage and fostering a circular economy.
Investing in the future of sustainable chemistry
The emergence of game-changing companies like Demeter Bio signals a significant investment opportunity. The high-impact ventures within Carbon13's portfolio demonstrate the calibre of innovation the programme consistently develops.
The Carbon13 SEIS Fund VIII provides investors with a vehicle to support the next wave of these groundbreaking startups. This fund offers access to a diversified portfolio of rigorously vetted companies, all targeting massive market opportunities with scalable solutions. All companies the fund invests in are expected to qualify for the UK Government’s Seed Enterprise Investment Scheme (SEIS), which is designed to incentivise investment in innovative, early-stage businesses by offering powerful tax reliefs, including up to 50% income tax relief, tax-free capital growth, and loss relief on investments that fail (tax reliefs are subject to individual circumstances).
For investors who aim to align their financial goals with positive planetary impact, the Carbon13 SEIS Fund VIII offers a powerful proposition: the chance to fund the growth of visionary businesses building a truly sustainable future.
Please note: our office hours are weekdays, 9.30am - 5.30pm.
